Abbott Laboratories (ABT) Debt Ratio (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Debt Ratio data on file, last reported at 0.31 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio rose 89.64% year-over-year to 0.31; the trailing twelve-month figure through Mar 2026 stood at 0.31 (up 89.64% YoY), and the FY2025 full-year result was 0.15, down 14.06% from the prior year.
• Debt Ratio advanced to 0.31 in Q1 2026, from 0.15 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 2.1 in Q4 2022 to a low of 0.15 in Q4 2025.
• A 5-year average of 0.32 and a median of 0.2 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio slumped 90.46% in 2023 and jumped 89.64% in 2026, its largest moves.
• Tracing ABT's Debt Ratio over 5 years: stood at 2.1 in 2022, then tumbled by 90.46% to 0.2 in 2023, then retreated by 13.47% to 0.17 in 2024, then slipped by 14.06% to 0.15 in 2025, then jumped by 106.78% to 0.31 in 2026.
• Business Quant data shows ABT's Debt Ratio at 0.31 in Q1 2026, 0.15 in Q4 2025, and 0.15 in Q3 2025.